158 related articles for article (PubMed ID: 14736837)
1. Why most PET of lung and head-and-neck cancer will be PET/CT.
Goerres GW; von Schulthess GK; Steinert HC
J Nucl Med; 2004 Jan; 45 Suppl 1():66S-71S. PubMed ID: 14736837
[TBL] [Abstract][Full Text] [Related]
2. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
[TBL] [Abstract][Full Text] [Related]
3. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
4. Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer.
Pfannenberg AC; Aschoff P; Brechtel K; Müller M; Bares R; Paulsen F; Scheiderbauer J; Friedel G; Claussen CD; Eschmann SM
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):36-44. PubMed ID: 16896664
[TBL] [Abstract][Full Text] [Related]
5. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer.
Yi CA; Lee KS; Kim BT; Shim SS; Chung MJ; Sung YM; Jeong SY
AJR Am J Roentgenol; 2007 Feb; 188(2):318-25. PubMed ID: 17242237
[TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.
Antoch G; Stattaus J; Nemat AT; Marnitz S; Beyer T; Kuehl H; Bockisch A; Debatin JF; Freudenberg LS
Radiology; 2003 Nov; 229(2):526-33. PubMed ID: 14512512
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
9. PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Freudenberg LS; Rosenbaum SJ; Beyer T; Bockisch A; Antoch G
Radiol Clin North Am; 2007 Jul; 45(4):639-44, v. PubMed ID: 17706528
[TBL] [Abstract][Full Text] [Related]
10. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT.
Antoch G; Freudenberg LS; Beyer T; Bockisch A; Debatin JF
J Nucl Med; 2004 Jan; 45 Suppl 1():56S-65S. PubMed ID: 14736836
[TBL] [Abstract][Full Text] [Related]
11. Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography.
Al-Sarraf N; Aziz R; Doddakula K; Gately K; Wilson L; McGovern E; Young V
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):350-3. PubMed ID: 17669863
[TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
13. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion.
Halpern BS; Schiepers C; Weber WA; Crawford TL; Fueger BJ; Phelps ME; Czernin J
Chest; 2005 Oct; 128(4):2289-97. PubMed ID: 16236886
[TBL] [Abstract][Full Text] [Related]
14. [Non small cell lung carcinoma - evaluation of tumor heterogeneity using CT texture analysis].
Manych M
Rofo; 2012 Nov; 184(11):978. PubMed ID: 23104480
[No Abstract] [Full Text] [Related]
15. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
16. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.
Dwamena BA; Sonnad SS; Angobaldo JO; Wahl RL
Radiology; 1999 Nov; 213(2):530-6. PubMed ID: 10551237
[TBL] [Abstract][Full Text] [Related]
17. Value of positron emission tomography for lung cancer staging.
Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
[TBL] [Abstract][Full Text] [Related]
18. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
19. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
20. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.
Lemke AJ; Niehues SM; Hosten N; Amthauer H; Boehmig M; Stroszczynski C; Rohlfing T; Rosewicz S; Felix R
J Nucl Med; 2004 Aug; 45(8):1279-86. PubMed ID: 15299049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
